Algorae Pharmaceuticals rises on distribution agreement with Dr Reddy's Laboratories
** Shares of Australia's Algorae Pharmaceuticals 1AI.AX rise as much as 15.4% to A$0.015, highest level since November 1, 2023 ** AI-enabled pharmaceutical co signs distribution agreement with Dr Reddy's Laboratories REDY.NS ** Agreement to supply chemotherapy medicine Capecitabine to Australian market ** About 10.6 mln shares change hands, 6.2x the 30-day average volume ** Stock has risen 150% this year, including session moves (Reporting by Roshan Thomas in Bengaluru) ((Roshan.Thomas@thomsonreuters.com;))
Recent news on Algorae Pharmaceuticals
See all newsAlgorae Pharmaceuticals rises on Australian distribution deal with India's Umedica
Brief: Algorae Pharmaceuticals Executes Licence & Supply Agreement With Umedica
Australia's Algorae Pharmaceuticals gains on Peter MacCallum Cancer Centre partnership
Brief: Algorae Pharmaceuticals Partners With Peter Maccallum Cancer Centre
Brief: Algorae Pharmaceuticals Named Launch Partner In Sovereign Ai Infrastructure Initiative